ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 149 filers reported holding ASCENDIS PHARMA A/S in Q1 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $34,523,097 | -10.4% | 253,139 | -0.7% | 3.30% | -14.0% |
Q1 2024 | $38,543,361 | +8.2% | 254,967 | -9.8% | 3.84% | -2.7% |
Q4 2023 | $35,611,607 | +33.0% | 282,744 | -1.1% | 3.95% | +18.9% |
Q3 2023 | $26,773,362 | +3.5% | 285,918 | -1.4% | 3.32% | +9.8% |
Q2 2023 | $25,870,005 | +0.9% | 289,860 | +21.3% | 3.02% | -1.8% |
Q1 2023 | $25,629,654 | -12.1% | 239,038 | +0.2% | 3.08% | -20.6% |
Q4 2022 | $29,142,783 | +24.1% | 238,621 | +4.9% | 3.88% | +20.1% |
Q3 2022 | $23,484,000 | +61.0% | 227,427 | +45.0% | 3.23% | +62.0% |
Q2 2022 | $14,585,000 | -10.0% | 156,900 | +13.7% | 1.99% | +27.6% |
Q1 2022 | $16,199,000 | -13.8% | 138,030 | -1.2% | 1.56% | -9.5% |
Q4 2021 | $18,790,000 | -2.4% | 139,673 | +15.6% | 1.73% | -10.4% |
Q3 2021 | $19,256,000 | +92.0% | 120,810 | +58.4% | 1.93% | +88.6% |
Q2 2021 | $10,031,000 | +3.7% | 76,252 | +1.6% | 1.02% | -9.1% |
Q1 2021 | $9,675,000 | -1.9% | 75,068 | +26.9% | 1.12% | -7.4% |
Q4 2020 | $9,863,000 | +46.4% | 59,136 | +35.4% | 1.21% | +14.6% |
Q3 2020 | $6,739,000 | +49.1% | 43,669 | +42.8% | 1.06% | +24.4% |
Q2 2020 | $4,521,000 | +30.6% | 30,571 | -0.6% | 0.85% | +1.8% |
Q1 2020 | $3,463,000 | +65.1% | 30,748 | +103.9% | 0.84% | +136.8% |
Q4 2019 | $2,098,000 | – | 15,079 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |